3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
10
Gastrointestinal
9
Breast
7
Other hematologic neoplasm
3
Endocrine
3
Lymphoid
2
Gynecologic
2
Genitourinary
2
Dermatologic
1
Classical hematology
1
Conditions
Melanoma
323
Skin Neoplasms
164
Carcinoma, Basal Cell
90
Keratosis, Actinic
62
Lymphoma, T-Cell, Cutaneous
60
Breast Neoplasms
59
Leukemia, Lymphocytic, Chronic, B-Cell
47
Precursor Cell Lymphoblastic Leukemia-Lymphoma
46
Mycosis Fungoides
46
Lymphoma, Non-Hodgkin
46
Sezary Syndrome
44
Lymphoma, Follicular
44
Lymphoma, Large B-Cell, Diffuse
43
Lymphoma, B-Cell, Marginal Zone
43
Lymphoma, Mantle-Cell
42
Burkitt Lymphoma
42
Hodgkin Disease
41
Carcinoma, Squamous Cell
41
Lymphoma, Large-Cell, Immunoblastic
40
Neoplasms
39
Multiple Myeloma
39
Lymphoma
39
Leukemia, Myeloid, Acute
35
Leukemia, Myeloid, Accelerated Phase
32
Myeloproliferative Disorders
31
Leukemia, Myeloid, Chronic-Phase
31
Congenital Abnormalities
30
Leukemia, Hairy Cell
29
Sarcoma
28
Primary Myelofibrosis
28
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Diabetes Mellitus, Type 2
×
Dermatologic
×
Clear all
NCT04726319
2026-05-06
FHAMe
University of Toronto
Phase NA
Completed
627 enrolled